Lydia Gaba - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic of Barcelona

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 79 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or Without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)

Beatriz Tavira,Teresa Iscar,Luis Manso,Ana Santaballa,Marta Gil-Martin, Garcia,Margarita Romeo,Maria Iglesias,Ana de Juan Ferre,Maria Pilar Barretina-Ginesta,Aranzazu Manzano,Lydia Gaba,Maria Jesus Rubio,Carlos E. de Andrea,Antonio Gonzalez-Martin

CLINICAL CANCER RESEARCHno. 1 (2024): 176-186

Cited0Views0WOSBibtex

Figure S2 from Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or Without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)

Beatriz Tavira,Teresa Iscar, Luis Manso,Ana Santaballa,Marta Gil-Martín, García,Margarita Romeo, María Iglesias,Ana de Juan Ferré,Maria-Pilar Barretina-Ginesta,Aránzazu Manzano,Lydia Gaba,María Jesús Rubio,Carlos E. de Andrea,Antonio González-Martín

openalex

Cited0Views0Bibtex

Supplementary Methods 1 from Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or Without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)

openalex（2024）

Cited0Views0Bibtex

Table S1 from Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or Without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)

openalex

Cited0Views0Bibtex

A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial

Future oncology (London, England)no. 13 (2024): 799-809

Cited0Views0WOSBibtex

Figure S3 from Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or Without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)

Beatriz Tavira,Teresa Iscar, Luis Manso, Ana Santaballa, Marta Gil-Martín, García,Margarita Romeo, María Iglesias,Ana de Juan Ferré,Maria-Pilar Barretina-Ginesta, Aránzazu Manzano,Lydia Gaba,María Jesús Rubio,Carlos E. de Andrea, Antonio González-Martín

openalex（2024）

Cited0Views0Bibtex

Efficacy and Safety of Alpelisib Plus Olaparib Versus Chemotherapy among Patients with Platinum-Resistant or Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation: Primary Analysis of the EPIK-O Trial

Panagiotis Konstantinopoulos, Jae-Weon Kim, Gilles Freyer,Jung-Yun Lee,Lydia Gaba,Rachel Grisham, Nicoletta Colombo,Xiaohua Wu,Jalid Sehouli, Felipe Cruz,David Cibula,Bradley Monk,Gitte-Bettina Nyvang,Michael Friedlander,Domenica Lorusso,Els Van Nieuwenhuysen,Rosalind Glasspool,Christian Marth, Patsy Hinson, Monica Zuradelli, Craig Wang,Faye Su,Michelle Miller,Ursula Matulonis,Antonio González-Martín

Gynecologic Oncology (2024)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn